Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

NCT07223983 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder
Weight Loss
Bariatric Surgery Patients

Interventions

DRUG: Semaglutide 1.0 mg

Sponsor

Yale University